Gut bacteria changes could be ‘warning sign for worsening Parkinson's symptoms'
They suggest the toxins could one day be used as 'markers' for medics to pinpoint the Parkinson's patients at a higher risk of dementia, as well as being used to help develop targeted treatments for the disease.
Parkinson's disease is a progressive condition that affects the brain, with symptoms including involuntary shaking, known as tremors, as well as psychological problems such as depression, loss of balance, trouble sleeping and memory issues.
According to the Alzheimer's Society, around a third of people with Parkinson's eventually develop dementia.
Dr Saeed Shoaie, group leader of the quantitative systems biology (QTS) lab at King's College London, said: 'The human gut and oral bacterial communities are increasingly linked to neurodegenerative diseases.
'Disruptions in the gut-brain axis could trigger inflammation and immune responses that contribute to neuronal damage.
'A common gum disease bacterium like porphyromonas gingivalis has been discovered as a potential driver of Alzheimer's.'
For the study, led by experts at King's College London and published in the journal Gut Microbes, scientists analysed 228 spit and stool samples.
The samples came from 41 patients with Parkinson's and mild cognitive impairment, which causes problems with thinking and memory, 47 patients with Parkinson's and dementia and 26 healthy patients.
The team found that the gut of people with mild cognitive impairment contained more harmful bacteria, many of which are likely to have come from the mouth.
This bacteria releases toxins that can damage gut tissue, promote inflammation and potentially affect the brain, according to researchers.
For a more in-depth analysis, the team used AI to pinpoint the bacterial species and functions not usually picked up by traditional testing, allowing them to link toxins specifically to cognitive decline.
Dr Shoaie added: 'The emerging evidence underscores the potential importance of maintaining oral and gut health in mitigating or slowing neurodegenerative processes.
'As people with Parkinson's become increasingly reliant on carers, routine practices such as oral hygiene and nutritional intake may be neglected.
'Our findings suggest that promoting a healthy microbiome through consistent oral care, a balanced diet and potentially targeted probiotic interventions could support improved disease management in Parkinson's.'
Dr Frederick Clasen, research associate at the QTS lab, said: 'We don't yet know if the bacteria are causing the cognitive decline or if changes in the body due to Parkinson's allow these bacteria to grow.
'But our findings suggest they may play an active role in worsening symptoms.'
Dr Clasen suggests these markers could one day be used to develop targeted treatments.
'These toxins could be used as biological markers to identify patients at higher risk of dementia in Parkinson's,' he said.
'In the future, they might also be targets for new treatments that protect the brain by changing the gut environment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
4 hours ago
- The Guardian
Margaret Boden obituary
Margaret Boden, who has died aged 88, explored and extended the philosophy of psychology and artificial intelligence (AI), and led the creation and growth of the School of Cognitive Sciences at the University of Sussex, an interdisciplinary crucible in which the careers of many prominent AI researchers were forged. Central to all Maggie's work was the study of mental phenomena, such as perception, thinking, consciousness and creativity, and how they arise from what are ultimately nothing more than mechanistic interactions – either biochemical interactions within the brain, or binary digits shuffling around the circuits of a computer. She wrote 15 books, co-authored another, and co-edited several collections of essays. Her works have been translated into 20 languages. Her first book, Purposive Explanation in Psychology (1972), was revised and extended from her 1968 Harvard PhD thesis. There she first advanced the novel argument that AI programs could be viewed as a type of theoretical psychology, allowing for the rigorous study of mental processes in abstract non-living systems, with the ultimate aim of revealing principles that could help us better understand mental processing in real living beings. Artificial Intelligence and Natural Man (1977) established her reputation as an authority on AI. It was a 537-page tour-de-force critical review and analysis of pretty much all progress in AI research up to the mid-1970s, presented to the reader in entertaining and accessibly non-technical terms. It is sometimes referred to as the world's first book on AI; the only other book that might contest this claim is Patrick Winston's Artificial Intelligence textbook, published in the same year. In the closing part of her book, Maggie explored the extent to which various types of AI system could be useful to advancing our understanding of human psychology; she discussed the philosophical issues raised by advances in AI, and pondered on the potential societal significance of the increased use of AI technologies in application areas such as education, law and healthcare and in creative acts such as composing music or writing poems – all topics current today. The issue of creativity in living and artificial systems was something that Maggie returned to repeatedly over the course of her career, extending her surveys and constructively critical analyses in books published in 1990, 1994 and 2010, and again in From Fingers to Digits: An Artificial Aesthetic (2019), which she co-authored with the digital artist Ernest Edmonds. Other books include a concise summary of the work of the Swiss psychologist Jean Piaget (1979), several on AI as theoretical psychology and on computer models of mind, The Philosophy of Artificial Intelligence (1990), followed by her edited collection The Philosophy of Artificial Life (1996); and her masterful two-volume set Mind As Machine: A History of Cognitive Science (2006), spanning almost 1,700 pages. As Maggie noted with characteristic candour in the introduction to Mind As Machine, she set out to write it as a historical essay, not as an encyclopedia: it was explicitly offered as her one-person view of cognitive science as a whole. Maggie started her academic career in 1959 as a lecturer in philosophy at the University of Birmingham. After spending 1962-64 in the US as a Harkness fellow at Harvard, she moved to the University of Sussex in 1965 as a lecturer in philosophy and psychology, becoming professor in 1980, a post she held until 2002, when she was appointed research professor of cognitive science, the title she held for the rest of her life. In 1974, Maggie, her philosopher colleague Aaron Sloman, and the computer vision researcher Max Clowes, jointly initiated Sussex's Cognitive Studies Programme (CSP), a radically novel attempt to bring together psychologists, linguists, philosophers and AI researchers, to collectively work on 'the study of mind'. Over time the CSP unit attracted academics who were keen to explore research questions at the outer borders of their fields, where their areas of expertise intersected with other disciplines. By the mid-80s the CSP was widely recognised as one of the two major centres for AI research in the UK (the other was the University of Edinburgh). By then the CSP had grown so large that in 1987 it became the autonomous School of Cognitive Sciences (known internally as 'Cogs'), the first new school at Sussex since its inception, with Maggie as the founding dean. She was determined that the new school would continue the traditions of the CSP, with an inclusive and collaborative community of interdisciplinary scholars. Cogs subsequently absorbed Sussex's Computer Science Department and was renamed the School of Cognitive and Computing Sciences. In 2003, another reorganisation led Cogs to be renamed the Sussex Centre for Cognitive Science, which it remains to this day, as a group of more than 50 academics drawn from across the university's four faculties. Maggie was elected a fellow of the British Academy in 1983, and served as the academy's vice-president during 1989-91; in 1993 she became a fellow of the American Association for AI; in 2001 she was appointed OBE; and in 2017 she received the ACM AAAI Allen Newell award. The University of Cambridge's Leverhulme Centre for the Future of Intelligence and the University of Sussex have both established annual lectures in her honour. Born in London, Maggie was the only surviving child of a civil servant, Leonard Boden, and his wife, Violet (nee Dawson), whose first child, Keith, had died as an infant before Maggie was born. From City of London school for girls she went to Newnham College, Cambridge, graduating in 1958 with a prize-winning first-class degree in medical sciences: it was there that her lifelong interest in mind and brain was first sparked. She chose to study at Cambridge rather than Oxford because she preferred the light blue Cambridge colours. In her vacations, she developed a longstanding love for the Cook Islands, and spent six weeks there each year for almost 30 years: she loved the drumming and the dancing, and was for a long time a keen snorkeller. She also became an accomplished scholar of Polynesia. Maggie was brilliant, fearless, iconoclastic, warm and funny, with an unquenchable thirst for conversation and intellectual debate. She almost always dressed in purple, adorned with unusual jewellery, and purple was the predominant colour used in Cogs for brochures, technical reports and official academic gowns. I spent a decade from 1987 in Cogs, joining as a PhD student and ending up as a lecturer. Maggie was immensely supportive. She provided the launchpad, the rocket and the fuel that enabled embryonic academic careers to take off. This, as much as the insightful arguments that she advanced, will be her lasting professional legacy. Maggie married the writer and publisher John Spiers in 1967; they divorced in 1981. She is survived by her son, Ruskin, and daughter, Jehane, and by her grandchildren, Byron, Oscar, Lukas and Alina. Margaret Ann Boden, philosopher, psychologist and cognitive scientist, born 26 November 1936; died 18 July 2025
Glasgow Times
a day ago
- Glasgow Times
Scottish Nobel chemist predicts Alzheimer's drug in 5 years
Professor David MacMillan, originally from North Lanarkshire and now based at Princeton University, told the BBC's Scotcast podcast: 'I would bet my house that within five years we have marketed drugs for Alzheimer's.' He said the rapid pace of development in neurological research gave him confidence that major treatment breakthroughs are close, calling the progress "phenomenal". READ MORE: Meet the 63-year-old 'Summer Santa' zip sliding along the Clyde for cancer care READ MORE: Huge new park and ride opens at busy train station near Glasgow MacMillan, whose father and aunt both suffered from dementia, was awarded the 2021 Nobel Prize in Chemistry alongside Professor Benjamin List for developing a revolutionary method of constructing molecules. Their discovery has already contributed to new approaches in treating Alzheimer's, as well as cancer and cardiovascular disease. He used his share of the prize money to launch The May and Billy MacMillan Foundation, named after his parents, to fund educational opportunities for underprivileged young Scots. Education, he said, was his 'passport to the world". Born in New Stevenston, MacMillan studied chemistry at the University of Glasgow before moving to the United States for postgraduate research. After academic posts at Harvard and Berkeley, he joined Princeton in 2006. While he has long praised the scale and ambition of American scientific research, MacMillan expressed concern about recent political pressure on universities. His Princeton research group, he said, has gone without government funding for seven months for the first time in 25 years. He attributed this to growing hostility towards higher education to the Trump-Vance administration. He warned that the cuts could reflect a broader attempt to exert political control over academic institutions, describing the trend as 'quite sinister.' Despite these challenges, MacMillan said he has no immediate plans to return to Scotland, though he visits regularly to see family and, now, a close friend. After winning the Nobel, he received an unexpected congratulatory call from Sir Alex Ferguson. The two Glaswegians have since become friends and plan to attend a Manchester United match together later this year. MacMillan's achievements have also been honoured in Scotland's National Portrait Gallery, where a new painting by Christabel Blackburn depicts him in his Princeton office. A lab coat from his former school, Bellshill Academy, hangs in the background – a quiet reminder of how far he has come.
Reuters
a day ago
- Reuters
Trump's lightning reactor build program ignites nuclear sector
July 31 - In a flurry of executive orders, President Trump has mandated the Department of Energy (DOE) to authorise and develop three pilot small modular reactors (SMRs) in a bid to accelerate nuclear power deployment and meet soaring demand from AI. The Trump administration wants the pilot reactors to achieve "criticality" by July 4, 2026, requiring completion of design, licensing and testing within a year. Trump also directed the Department of Defense (DOD) to commission its own pilot reactor within three years. SMRs promise lower upfront capital costs and shorter construction times than conventional large reactors, but first of a kind (FOAK) designs have taken years to gain regulatory approval and investors have been wary of development and construction risks. Soaring demand from Big Tech has catalysed interest in nuclear power and developers say small reactors can be built in line with rising demand from data centers. Trump's executive orders also directed the Nuclear Regulatory Commission (NRC) to process licence approvals for new reactors within 18 months and establish a process for "high-volume licensing of micro reactors and modular reactors, including allowing for standardized applications." The DOE and DOD will seek to source private funding for the construction and operation of nuclear fuel recycling, reprocessing, and fabrication capabilities, the White House said. The government aims to increase U.S. nuclear capacity from about 100 GW today to 400 GW by 2050 and only three large reactors have entered commercial operation this century. CHART: Annual US nuclear power installations DOE authorization of SMR designs will help unlock private funding, provide a fast-track licensing approach and help establish the required supply chains and talent pipeline, a DOE spokesperson told Reuters Events. The executive orders provide a "much-needed catalyst" for SMR deployment in the civilian sector by "circumventing some of the structural and regulatory bottlenecks that have historically slowed down progress,' James Walker, CEO of micro reactor developer Nano Nuclear Energy, said. The federal actions will effectively guarantee initial customers and testing grounds for new reactors, unlock procurement pathways and create viable use cases, Walker said. Faster deployment The DOE closed its application window for reactor developers on June 21 and applications will be assessed based on criteria including technological readiness, siting evaluations, financial viability and a detailed plan for achieving criticality. The DOE is seeking designs that have a "reasonable chance' of achieving criticality by July 2026, the DOE spokesperson said. To speed up the process, the department is streamlining its authorization process and eliminating or expediting its environmental reviews for permits and approvals, the spokesperson noted. CHART: Small modular reactor projects by country Developing projects on DOE and DOD land should shorten approval and deployment timelines. The DOE-owned Idaho National Laboratory (INL) is one potential location for the test reactors, as well as Sandia National Labs which has sites in New Mexico and California, as well as numerous DOD sites. Shifting the deployment of FOAK reactors onto lands under DOE or DOD control will help to remove obstacles to development, Walker said. FOAK reactors 'often languish due to lack of customers and high regulatory uncertainty,' Walker said. The executive orders require the NRC to expedite the approval process for designs that the DOE or DOD have demonstrated have the ability to function safely. Download exclusive insights from the Reuters Events: SMR & Advanced Reactor 2025 conference in May. Applicants will be responsible for all design, manufacturing, construction, operating and decommissioning costs. While the projects will not receive federal funding, the DOE will provide federal resources as part of the application process, the DOE spokesperson noted. The executive orders could see multiple FOAK reactors deployed by the end of the decade and these reactors will each generate operational data, workforce expertise and bolster public confidence to catalyze the commercial market, Walker said. 'Difficult' deadline Developers of micro reactors or SMRs that have high technology readiness and a clear pathway to manufacturing will benefit most from the federal development initiatives, Walker said. Companies like BWX, Holtec, Westinghouse and NuScale are developing SMRs based on existing light water reactor (LWR) technology but a number of advanced reactor developers and micro reactor developers are also seeking to deploy rapidly in the coming years and signing early commercial arrangements with large offtakers including tech groups. Trump's orders could "ensure we get more near term deployment of known technologies' but might not help 'more exotic or 4th generation [nuclear] tech," Patrick O'Brien, Director, Government Affairs and Communications at Holtec International, told Reuters Events. Holtec is one of a small group of developers seeking to win DOE funds for SMRs based on LWR technology, allocated through a separate funding round. For exclusive nuclear insights, sign up to our newsletter. Micro reactors would be more likely to achieve the criticality deadline of July 2026 on federal sites, due to their smaller size, O'Brien said. Building a whole advanced reactor system in a year would be 'extremely difficult' because of supply chain constraints, Walker warned. Instead, the DOE could adjust its definition of criticality to specify that only fuel assembly rather than the entire reactor must reach criticality by the July 2026 deadline, he said.
